TRANSPLANT-RELATED DISORDER
Clinical trials for TRANSPLANT-RELATED DISORDER explained in plain language.
Never miss a new study
Get alerted when new TRANSPLANT-RELATED DISORDER trials appear
Sign up with your email to follow new studies for TRANSPLANT-RELATED DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Targeted radiation before transplant could give leukemia patients a fighting chance
Disease control Not yet recruitingThis study tests a new approach for people with relapsed or refractory acute myeloid leukemia (AML) who have active disease. Before a stem cell transplant, patients receive a targeted radiation drug (131I-apamistamab) along with standard chemotherapy and low-dose whole-body radia…
Matched conditions: TRANSPLANT-RELATED DISORDER
Phase: PHASE2, PHASE3 • Sponsor: Actinium Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 06:08 UTC
-
New model aims to predict and prevent deadly transplant complication
Disease control Not yet recruitingThis study tests whether giving the drug ruxolitinib early can prevent severe graft-versus-host disease (GvHD) in adults receiving a stem cell transplant from a half-matched donor. The trial uses a special model (daGOAT) to identify patients at highest risk. About 438 participant…
Matched conditions: TRANSPLANT-RELATED DISORDER
Phase: PHASE3 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 20, 2026 11:53 UTC